Emory Saint Joseph’s Hospital Earns Elite “TAVR” Procedure Status

Emory Saint Joseph’s Hospital has earned a distinguished three-star rating from the Society of Thoracic Surgeons (STS) and the American College of Cardiology (ACC) for its patient care and outcomes in transcatheter aortic valve replacement (TAVR).

The three-star rating, which denotes the highest category of quality, places the hospital among an elite few for the TAVR procedure in the United States and Canada.

During a TAVR procedure, a doctor uses a catheter inserted into a patient’s blood vessel to deliver a prosthetic heart valve, replacing the patient’s impaired valve. 

“This three-star rating affirms Emory Saint Joseph’s Hospital as a leader in quality for the TAVR procedure, which is increasingly becoming a top-choice method to treat valve dysfunction in a minimally-invasive way, leading to faster recoveries and better outcomes for our patients,” says George Hanzel, interventional cardiologist and director of the cardiac catheterization lab at the hospital.